Therefore, prediction accuracy for oligodendroglioma based on diagnosis and alteration status for IDH status and TP53 as determined by Oncomine was 100% compared to both IHC and Foundation Medicine results (Table 3). The gene discussed is IDH1; the disease is oligodendroglioma.